Recent Patents on AntiCancer Drug Discovery
Home
FOR AUTHORS
ARTICLES
SUBSCRIBERS & CORPORATES
FOR REVIEWERS
CONTENTS & ABSTRACTS
CONTACT US
Monday, January 22, 2018
New Issue Published Recent Patents on Anti-Cancer Drug Discovery Vol. 13 Issue 1
1:44 AM
No comments
New Issue Published Recent Patents on Anti-Cancer Drug Discovery Vol. 13 Issue 1
Read More
Monday, November 27, 2017
New Issue Published Recent Patents on Anti-Cancer Drug Discovery Vol. 12 Issue 4
8:49 PM
No comments
New Issue Published Recent Patents on Anti-Cancer Drug Discovery Vol. 12 Issue 4
Read More
Monday, October 16, 2017
Most Citied Article : HSP90 Inhibitors: Current Development and Potential in Cancer Therapy
12:23 AM
No comments
Most Citied Article : HSP90 Inhibitors: Current Development and Potential in Cancer Therapy
Read More
Monday, October 9, 2017
Free Trial Request
12:33 AM
No comments
Free Trial Request
Read More
Monday, October 2, 2017
Most Accessed Article : Marine Derived Anticancer Drugs Targeting Microtubule
12:53 AM
No comments
Most Accessed Article : Marine Derived Anticancer Drugs Targeting Microtubule
Read More
Wednesday, September 6, 2017
New Issue Published Recent Patents on Anti-Cancer Drug Discovery Vol. 12 Issue 3.
2:57 AM
No comments
New Issue Published Recent Patents on Anti-Cancer Drug Discovery Vol. 12 Issue 3.
Read More
Tuesday, September 5, 2017
Most Cited Article: HSP90 Inhibitors: Current Development and Potential in Cancer Therapy
2:30 AM
No comments
Most Cited Article: HSP90 Inhibitors: Current Development and Potential in Cancer Therapy
Read More
Older Posts
Home
Social Profiles
Popular
Tags
Blog Archives
New Issue::: Recent Patents on Anti-Cancer Drug Discovery, 11 Issue 1
Recent Patents on Anti-Cancer Drug Discovery publishes review and research articles, and guest edited thematic issues on recent patents ...
Most cited articles from the jorunal ‘Recent Patents on Anti-Cancer Drug Discovery’
Involvement of Endoplasmic Reticulum Stress in Isoliquiritigenin-Induced SKOV-3 Cell Apoptosis Author(s): Xuan Yuan, Bacui Yu, Yanming...
Open Access Plus ::: Recent Patents on Anti-Cancer Drug Discovery
Open Access Plus ::: Recent Patents on Anti-Cancer Drug Discovery Circulatory Estrogen Level Protects Against Breast Cancer in Obese...
Video presentation on the journal ‘Recent Patents on Anti-Cancer Drug Discovery ‘
Recent Patents on Anti-Cancer Drug Discovery publishes review and research articles, and guest edited thematic issues on recent pat...
Circulatory Estrogen Level Protects Against Breast Cancer in Obese Women
Author(s): Zsuzsanna SubaPages 154-167 (14) Abstract: Literary data suggest apparently ambiguous interaction between menopausal status...
Most Cited Article: HSP90 Inhibitors: Current Development and Potential in Cancer Therapy
HSP90 Inhibitors: Current Development and Potential in Cancer Therapy Author(s): Katerina Sidera and Evangelia PatsavoudiPages 1-20 (...
Issue Publish Recent Patents on Anti-Cancer Drug Discovery
New Issue Publish Recent Patents on Anti Cancer Dru Discovery Vol. 11 Issue 4.
Most Citied Article : HSP90 Inhibitors: Current Development and Potential in Cancer Therapy
Most Citied Article : HSP90 Inhibitors: Current Development and Potential in Cancer Therapy
Aldo-Keto Reductase Family 1 Member B10 Inhibitors: Potential Drugs for Cancer Treatment
Author(s): Li Huang, Rongzhang He, Weihao Luo, Yuan-Shan Zhu, Jia Li, Tan Tan, Xi Zhang, Zheng Hu and Dixian LuoPages 184-196 (13) Abst...
Open Access Article: "Activating Mutations of ESR1, BRCA1 and CYP19 Aromatase Genes Confer Tumor Response "
Open Access Article: "Activating Mutations of ESR1, BRCA1 and CYP19 Aromatase Genes Confer Tumor Response "
Blog Archive
▼
2018
(1)
▼
January
(1)
New Issue Published Recent Patents on Anti-Cancer ...
►
2017
(34)
►
November
(1)
►
October
(3)
►
September
(2)
►
August
(3)
►
July
(4)
►
June
(3)
►
May
(3)
►
April
(3)
►
March
(4)
►
February
(2)
►
January
(6)
►
2016
(22)
►
December
(5)
►
November
(5)
►
October
(7)
►
August
(1)
►
June
(4)
Blogger templates
Aldo-Keto Reductase Family 1 Member B10 Inhibitors: Potential Drugs for Cancer Treatment
Causal Therapy of Breast Cancer Irrelevant of Age, Tumor Stage and ER-Status: Stimulation of Estrogen Signaling Coupled With Breast Conserving Surgery
Circulatory Estrogen Level Protects Against Breast Cancer in Obese Women
Regulating TRAIL Receptor-Induced Cell Death at the Membrane: A Deadly Discussion